0001104659-20-117614.txt : 20201023
0001104659-20-117614.hdr.sgml : 20201023
20201023132306
ACCESSION NUMBER: 0001104659-20-117614
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201023
FILED AS OF DATE: 20201023
DATE AS OF CHANGE: 20201023
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAPADOPOULOS STELIOS
CENTRAL INDEX KEY: 0001202098
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39650
FILM NUMBER: 201257060
MAIL ADDRESS:
STREET 1: 3 SOMERSET DRIVE SOUTH
CITY: GREAT NECK
STATE: NY
ZIP: 11020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eucrates Biomedical Acquisition Corp.
CENTRAL INDEX KEY: 0001822929
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
BUSINESS ADDRESS:
STREET 1: 250 WEST 55TH STREET, SUITE 13D
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: (212) 710-5220
MAIL ADDRESS:
STREET 1: 250 WEST 55TH STREET, SUITE 13D
CITY: NEW YORK
STATE: NY
ZIP: 10019
3
1
tm2034126-6_3.xml
FORM 3
X0206
3
2020-10-23
0
0001822929
Eucrates Biomedical Acquisition Corp.
EUCR
0001202098
PAPADOPOULOS STELIOS
C/O EUCRATES BIOMEDICAL ACQUISITION CORP
250 WEST 55TH STREET, SUITE 13D
NEW YORK
NY
10019
1
0
1
0
Ordinary Shares
2875000
I
See Footnote
These shares represent ordinary shares held by the issuer's sponsor, Eucrates LLC. The shares held by the sponsor are beneficially owned by each of Parag Saxena and Stelios Papadopoulos, the issuer's Chief Executive Officer and Chairman, respectively, and the managing members of the sponsor, who have joint voting and dispositive power over the shares held by the sponsor. These shares include up to an aggregate of 375,000 ordinary shares subject to forfeiture by the sponsor to the extent that the underwriters' over-allotment option is not exercised in full. Mr. Saxena and Mr. Papadopoulos disclaim beneficial ownership over any securities owned by the sponsor in which they do not have any pecuniary interest.
/s/ Stelios Papadopoulos
2020-10-23